|
[1]
|
Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine,
2022
DOI:10.1186/s13049-022-01060-y
|
|
|
|
|
[2]
|
Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine,
2022
DOI:10.1186/s13049-022-01060-y
|
|
|
|
|
[3]
|
Pharmacodynamic properties for inhibition of cAMP- and cGMP elimination by pentoxifylline remain unaltered in vitro during hypothermia
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine,
2022
DOI:10.1186/s13049-022-01060-y
|
|
|
|
|
[4]
|
Treatment of Cardiovascular Dysfunction With PDE5-Inhibitors – Temperature Dependent Effects on Transport and Metabolism of cAMP and cGMP
Frontiers in Physiology,
2021
DOI:10.3389/fphys.2021.695779
|
|
|
|
|
[5]
|
Inhibition of ABCC5-mediated cGMP transport by progesterone, testosterone and their analogues
The Journal of Steroid Biochemistry and Molecular Biology,
2021
DOI:10.1016/j.jsbmb.2021.105951
|
|
|
|
|
[6]
|
Identification and experimental confirmation of novel cGMP efflux inhibitors by virtual ligand screening of vardenafil-analogues
Biomedicine & Pharmacotherapy,
2020
DOI:10.1016/j.biopha.2020.110109
|
|
|
|
|
[7]
|
The role of OAT2 (SLC22A7) in the cyclic nucleotide biokinetics of human erythrocytes
Journal of Cellular Physiology,
2018
DOI:10.1002/jcp.26409
|
|
|
|
|
[8]
|
Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
Journal of Pharmacy and Pharmacology,
2017
DOI:10.1111/jphp.12693
|
|
|
|
|
[9]
|
Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux
Journal of Pharmacy and Pharmacology,
2017
DOI:10.1111/jphp.12693
|
|
|
|
|
[10]
|
The Effect of MRP5-Expression on Human Erythroleukemia (HEL) Cell Growth and cGMP Levels
Pharmacology & Pharmacy,
2016
DOI:10.4236/pp.2016.71009
|
|
|
|
|
[11]
|
Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors
European Journal of Pharmacology,
2014
DOI:10.1016/j.ejphar.2014.10.051
|
|
|
|